Work

Early time of day of administration of immunochemotherapy for enhancing overall survival in patients with lung cancer irrespective of histological type?

Year: 2026

Type: article

Abstract: The striking clinical relevance of the circadian immune system for patients with advanced lung cancer is supported by consistent overall survival prolongation through early time of day of immunochemotherapy, no matter the histological type.

Source: Cancer

DOI: 10.1002/cncr.70290

Author: Francis A. Lévi

Institutions: Inserm, Université Paris-Saclay, University of Warwick, Assistance Publique – Hôpitaux de Paris, Hôpital Paul-Brousse

Language: English

Topic: Circadian rhythm and melatonin

Subfield: Endocrine and Autonomic Systems

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Institut National de la Santé et de la Recherche Médicale